AbbVie, Inc. (ABBV)
264.49
-0.47
(-0.18%)
USD |
NYSE |
Aug 24, 16:00
264.58
+0.09
(+0.03%)
After-Hours: 20:00
AbbVie Price : 264.49 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 260.70 | 266.84 | 260.10 | 264.96 | 5.157M |
| Aug 20, 2026 | 265.69 | 265.93 | 260.48 | 261.83 | 5.229M |
| Aug 19, 2026 | 261.51 | 266.96 | 259.55 | 265.97 | 5.536M |
| Aug 18, 2026 | 253.93 | 259.18 | 252.41 | 258.92 | 5.010M |
| Aug 17, 2026 | 249.49 | 251.49 | 248.31 | 250.33 | 4.649M |
| Aug 14, 2026 | 250.60 | 250.61 | 247.68 | 249.46 | 4.195M |
| Aug 13, 2026 | 252.94 | 255.30 | 249.35 | 250.82 | 4.370M |
| Aug 12, 2026 | 245.98 | 250.09 | 245.52 | 248.76 | 3.780M |
| Aug 11, 2026 | 248.14 | 250.76 | 247.18 | 250.09 | 4.485M |
| Aug 10, 2026 | 245.65 | 248.01 | 244.03 | 247.97 | 4.210M |
| Aug 07, 2026 | 243.62 | 246.76 | 241.95 | 246.04 | 4.931M |
| Aug 06, 2026 | 249.04 | 249.95 | 241.20 | 243.87 | 4.570M |
| Aug 05, 2026 | 247.00 | 249.38 | 243.76 | 246.20 | 5.194M |
| Aug 04, 2026 | 246.74 | 246.91 | 242.38 | 243.80 | 8.029M |
| Aug 03, 2026 | 251.45 | 256.20 | 244.44 | 245.10 | 7.436M |
| Jul 31, 2026 | 252.54 | 255.52 | 247.00 | 250.94 | 7.258M |
| Jul 30, 2026 | 258.38 | 259.89 | 253.51 | 257.41 | 6.407M |
| Jul 29, 2026 | 264.21 | 267.47 | 262.76 | 263.30 | 5.564M |
| Jul 28, 2026 | 262.83 | 266.92 | 261.45 | 263.20 | 7.060M |
| Jul 27, 2026 | 259.00 | 262.10 | 256.78 | 256.91 | 5.405M |
| Jul 24, 2026 | 258.54 | 260.22 | 256.76 | 259.36 | 4.195M |
| Jul 23, 2026 | 253.98 | 258.38 | 253.10 | 256.92 | 4.623M |
| Jul 22, 2026 | 257.81 | 257.81 | 252.25 | 253.30 | 4.953M |
| Jul 21, 2026 | 253.70 | 257.06 | 252.60 | 256.10 | 4.819M |
| Jul 20, 2026 | 253.10 | 256.15 | 252.68 | 253.38 | 4.333M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 218.11 |
| Gilead Sciences, Inc. | 146.76 |
| Regeneron Pharmaceuticals, Inc. | 828.72 |
| Amgen, Inc. | 443.84 |
| REGENXBIO, Inc. | 8.06 |
Price Related Metrics
| PE Ratio | 74.78 |
| PS Ratio | 7.282 |
| PEG Ratio | 1.095 |
| Price to Free Cash Flow | 25.75 |
| Earnings Yield | 1.34% |
| Market Cap | 467.37B |
| PEGY Ratio | 1.055 |
| Operating PE Ratio | 21.30 |
| Normalized PE Ratio | 32.85 |